Funding for human papillomavirus (HPV) research and development (R&D) worldwide 2018
In 2018, around 31.1 million U.S. dollars were spent worldwide on the research and development of preventive vaccines for human papillomavirus (HPV). This statistic shows human papillomavirus (HPV) and HPV-related cervical cancer research and development (R&D) funding worldwide in 2018, in million U.S. dollars.